Skip navigation

The Latest Strategies and Financial/Tax Implications for Structuring and Executing Corporate Transactions

June 27, 2018
  • Philadelphia, PA

2018 has already ushered in a wave of mergers and acquisitions within the life sciences industry. The corporate tax overhaul lays the underpinnings of this trend, with many more deals expected. CBI’s new M&A Playbook for Life Science Companies is a comprehensive guide to negotiating, crafting, measuring and reporting on strategic deals and transactions. Gain expert insight on the financial and tax implications of prevailing deal models and learn strategies for effective deal execution, transition and reporting.

By Attending You Gain:

  • CPE and CLE credits centered-on highly focused content,
    specific for life science companies
  • Analyst insight on deal valuations
  • Up to the minute insight on the implications of
    new tax structure on deal-making
  • Opportunity for peer-to-peer benchmarking
  • Professional development

M&A Playbook for Life Science Companies

The Latest Strategies and Financial/Tax Implications for Structuring and Executing Corporate Transactions

2018 has already ushered in a wave of mergers and acquisitions within the life sciences industry. The corporate tax overhaul lays the underpinnings of this trend, with many more deals expected. CBI’s new M&A Playbook for Life Science Companies is a comprehensive guide to negotiating, crafting, measuring and reporting on strategic deals and transactions. Gain expert insight on the financial and tax implications of prevailing deal models and learn strategies for effective deal execution, transition and reporting.

By Attending You Gain:

  • CPE and CLE credits centered-on highly focused content,
    specific for life science companies
  • Analyst insight on deal valuations
  • Up to the minute insight on the implications of
    new tax structure on deal-making
  • Opportunity for peer-to-peer benchmarking
  • Professional development